Trial Details
COMPLETEDBasic Information
| Clinical ID | c1055 |
|---|---|
| Identifier | NCT02611830 |
| Trial Title | Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Vedolizumab 300 mg IV|DRUG: Placebo IV|DRUG: Vedolizumab 108 mg SC|DRUG: Placebo SC |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Little Rock |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2015-12-18 |
|---|---|
| Primary Completion Date | 2018-05-30 |
| Completion Date | 2018-08-21 |